Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04766424 · ClinicalTrials.gov registry record · NA
Sleep Technology Intervention to Target Cardiometabolic Health
A NA study of Elevated Blood Pressure and Habitual Sleep Duration of Less Than or Equal to 7 Hours, sponsored by University of Utah.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04766424: Active NA study of Elevated Blood Pressure and Habitual Sleep Duration of Less Than or Equal to 7 Hours, sponsored by University of Utah.
NCT04766424 is a NA study of Elevated Blood Pressure and Habitual Sleep Duration of Less Than or Equal to 7 Hours that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 120 participants, above the 93-participant average among 6 other Elevated Blood Pressure trials with a reported enrollment target (29% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04766424, a NA study of Elevated Blood Pressure and Habitual Sleep Duration of Less Than or Equal to 7 Hours, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to test the efficacy of a behavioral sleep extension intervention on sleep duration, cardio-metabolic disease risk factors, and health behaviors among adults with elevated blood pressure/hypertension and short sleep duration.
Conditions Studied
Interventions
- BEHAVIORAL Health education
- BEHAVIORAL Sleep extension intervention
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-03-30 |
| Est. Completion | 2025-06-14 |
| Phase | NA |
What the registry record for NCT04766424 still lists
NCT04766424 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 93-participant average among 6 other Elevated Blood Pressure trials with a reported enrollment target (29% higher).
The record links to 2 conditions, with Elevated Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Health education is the first listed.
NCT04766424 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT04766424 about?
NCT04766424 is a clinical study titled "Sleep Technology Intervention to Target Cardiometabolic Health". The goal of this study is to test the efficacy of a behavioral sleep extension intervention on sleep duration, cardio-metabolic disease risk factors, and health behaviors among adults with elevated blood pressure/hypertension and short sleep duration.
What is the current status of trial NCT04766424?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2021-03-30. Estimated completion is 2025-06-14.
What conditions does trial NCT04766424 study?
This clinical trial studies the following conditions: Elevated Blood Pressure, Habitual Sleep Duration of Less Than or Equal to 7 Hours.
What interventions are being tested in trial NCT04766424?
The interventions under investigation include: Health education (BEHAVIORAL), Sleep extension intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04766424?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04766424 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Elevated Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-exercise Hot Water Immersion to Improve Overnight Blood Pressure
RECRUITING · NA
-
Groceries for Residents of Southeastern USA to Stop Hypertension
RECRUITING · NA
-
A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
RECRUITING · NA
-
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
ACTIVE NOT RECRUITING · NA
-
The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.
COMPLETED · NA
-
Office, Home, and Ambulatory Blood Pressure
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI